ARCHIVES

Protocols Approved By NCI During January 2004

This article is from The Cancer Letter archive.

Vol. 27 No. 2 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013

ASCO: NCI Director Should Be A Clinician; NBCC Endorses Mary-Claire King

March 10, 1995

New International Policy On Clinical Trials Is Needed, Veronesi Says

October 21, 1983

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

CPRU Program Gets Basic Concept Approval

October 2, 1987

Hormonal Therapy Improves Prostate Cancer Survival

August 27, 2004